PDCD1 and hepatocellular carcinoma: This study utilized helical I-125 seed implantation, TACE and sorafenib as the historical control group to comparatively analyze the efficacy and safety of helical I-125 seed implantation combined with TACE, lenvatinib, and PD-1 inhibitors in the treatment of HCC with MPVTT.